Therefore, in this prospective study, we aimed to investigate ABO antibody levels, including IgM, IgG and IgA isotypes, in the serum and saliva of non-hospitalised patients who recovered from mild COVID-19 and to compare them with those of individuals who had never been infected with the virus. This evidence concerns the gene ABO and COVID-19.